News
Opinion
22hon MSNOpinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.
After 100 days as FDA Commissioner, Dr. Marty Makary lays out his vision for reform, starting with the broken systems he's ...
FDA Commissioner Marty Makary said the agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost ...
Food and Drug Administration Commissioner Marty Makary said his agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the US and other ...
By publishing more than 200 complete response letters, the FDA is offering new visibility into the issues that most often ...
FDA says the move boosts regulatory transparency, offering insights into common approval barriers in drug applications and reducing guesswork.
"For decades, menopause has been overlooked in both clinical research and health care policy, largely because it affects ...
Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.
Futures on Wall Street have tanked in the early hours of Friday morning Indian time, after US President Donald Trump teased a ...
Rezolve AI PLC (NASDAQ:RZLV) is one of the most popular AI penny stocks to buy according to billionaires. On June 26, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results